New USP Chapter on Moisture Barrier of Plastic Packaging Systems
The USP published a draft of a new general chapter on the Application of Moisture Vapor Transmission Rates for Solid Oral Dosage Forms in Plastic Packaging Systems. Additionally the general chapter Containers—Performance Testing <671> has been revised and published for comment in the same issue of PF.
Packaging materials: DIN standard on migration published
Together with project partners from industry and research & development, five associations have agreed on a testing method for evaluation of migration from paper and paperboard. Read more about the migration standard.
Must each container of a starting material be sampled for identification?
This question has been adopted by Health Canada in their "Good Manufacturing Practices (GMP) Questions and Answers". Read here, what recommendations the Canadian authority gives for sampling APIs and excipients.
Warning letter due to non-validated Analytical Methods
Procedures for the analysis of GMP-liable products must be validated. Read here, what deficiencies involving the validation of analytical methods and the handling of OOS results almost inevitably lead to a Warning Letter.
FDA Warning Letter due to not functioning HPLC Audit Trail
The Chinese API manufacturer Lijiang Yinghua Biochemical and Pharmaceutical Co., Ltd. received an FDA warning letter in April 2018. During the FDA inspection, the deletion of electronic data of HPLC and GC analyses and the mulfunctioning of the Audit Trail of the laboratory instruments were particularly criticised.
Revised Ph. Eur. Monographs on Excipients due to ICH Q3D
Several Ph. Eur. Monographs on excipients used in semi-solid formulations have been proposed for comment. Read more about the monographs on oils, fats, waxes, emulsifiers.
New USP Chapter <1210> Statistical Tools for Procedure Validation
The final USP General Chapter <1210> has been published. It will become official on May 1, 2018. Read more about Statistical Tools for Procedure Validation.
Several revised Ph. Eur. packaging chapters have been recently adopted by the Ph. Eur. Commission. These general chapters will appear in Ph. Eur. 9.6. Read more about the revised chapters on plasticized PVC materials and glass containers.
Warning Letter for systematic invalidating of OOS Results
If inspectors find deficiencies in quality control, they usually make sure to go into detail. Find out in which cases the invalidating of OOS results and exceeded bulk hold times are not tolerated in FDA inspections.
Can the (√n+1) Rule be accepted in Sampling Plans?
Is a sampling plan based on the (√n+1) rule acceptable for determining the correct number of samples? Health Canada took up this question in their "Good Manufacturing Practices (GMP) Questions and Answers". Read more under which conditions the use of sampling key (√n+1) is possible.
On 27 November, 2017, the EMA's Committee on Herbal Medicinal Products (HMPC) published the HMPC meeting report about their 79. meeting held from 20-21 November, 2017. Learn more about the key issues discussed during the EMA HMPC meeting.
Chinese manufacturer Zhejiang Ludao Technology received an FDA Warning Letter in February, 2018. During the FDA inspection, the missing Audit Trail Review for the HPLC system was particularly criticised.
Microbiological testing of topical drug products to prove compliance with the specifications prior to release and correct labelling is mandatory for products applied to the skin. Find out, what GMP violations regarding the manufacturing, testing and labelling FDA inspectors found during an inspection.
Drafts of USP Packaging Chapters to be redeveloped
The USP recently posted the announcement of its intent to cancel and redevelop the drafts of packaging chapters previously published in the Pharmacopeial Forum. Read more about USP´s chapters on glass containers and elastomeric closures.